Table 1. Surgical and pathological characteristics.
| Variables | Values | |
|---|---|---|
| Age at diagnosis | 67.9±10.3 | |
| BMI | 27.5±5.5 | |
| Histology | ||
| Squamous | 75 (96.2) | |
| Adenocarcinoma | 3 (3.8) | |
| Grade | ||
| 1 | 16 (20.5) | |
| 2 | 33 (42.3) | |
| 3 | 15 (19.2) | |
| Missing | 14 (17.9) | |
| FIGO stage | ||
| IA | 11 (14.1) | |
| IB | 23 (29.5) | |
| II | 13 (16.7) | |
| III | 14 (17.9) | |
| IV | 6 (7.7) | |
| Missing | 11 (14.1) | |
| Symptoms at diagnosis | ||
| Bleeding | 8 (10.3) | |
| Pruritus | 36 (46.2) | |
| Mass | 10 (12.8) | |
| ACCI score | ||
| Low risk (0–1) | 12 (15.4) | |
| Intermediate risk (2–3) | 36 (46.2) | |
| High risk (>3) | 30 (38.5) | |
| Surgical procedure | ||
| Skin vulvectomy | 3 (3.8) | |
| Local excision | 11 (14.1) | |
| Hemivulvectomy | 29 (37.2) | |
| Radical vulvectomy | 35 (44.9) | |
| Flap | 21 (26.9) | |
| Monolateral lymphadenectomy | 18 (23.1) | |
| Bilateral lymphadenectomy | 47 (60.3) | |
| Tumor size (mm) | 29.4±17.9 | |
| Tumor-free resection margins | ||
| >10 mm | 48 (61.5) | |
| >5 mm | 12 (15.4) | |
| 5 mm | 11 (14.1) | |
| Infiltrated | 7 (9) | |
| Number of removed lymph nodes | 16.6±11.9 | |
| Node positive patients | 19 (24.4) | |
| Number of positive nodes* | 3.3±3.4 | |
Values are presented as number of patients (%) or mean±standard deviation.
ACCI, age-adjusted Charlson comorbidity index; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics.
*Among positive-node patients.